On the "Management" and "Theory" of Safety Civilization"
Release time:
2020-07-22
On the "Management" and "Management" of Safety Civilization
Safety civilization slogans such as "Safety First, Life First", "Strengthening Safety Awareness" and "No Smoking" can be seen everywhere in the streets and all kinds of public places. The safe and civilized production rules and regulations and safe operation specifications in enterprises are set in one set, one book and complete, the key is how to root these safety concepts and safety awareness into everyone's mind. This not only requires managers at all levels to "tirelessly, tirelessly, and rigorously" to conduct propaganda and indoctrination, but also requires tough management methods.
The same individual, the same environment, may behave differently under different conditions. For example, when the same individual rides a non-motorized vehicle and drives a motor vehicle at a red light at an intersection, he may run a red light when riding a non-motorized vehicle, but he does not dare to drive a motor vehicle. The reason is that there is a complete supervision system and subsequent strict supervision at the intersection. Punishment measures; another example is that the same individual secretly smokes in general no-smoking areas, but dare not smoke on high-speed trains or airplanes, the reason is that there are monitoring blind spots in general no-smoking areas, while there are omni-directional and full-process monitoring systems and strict penalties on high-speed railways or airplanes. Looking at the development of human security civilization, it is not sudden, but the experience and lessons learned from countless painful experiences in the long-term life and production process. After gradual accumulation and summary, a series of codes of conduct to regulate people's daily life and production activities have been formulated. However, in real life, it is not uncommon for pedestrians not to take zebra crossings, battery cars running red lights, smoking in public places, and no-smoking places. The reason is that even if it is the bad elements of some people, there are gaps in the supervision area and inadequate management measures. Is the biggest factor. There are also some enterprises or safety accidents caused by imperfect safety measures or illegal operation of employees occur from time to time, resulting in immeasurable losses of personnel and property.
Jinhua Pharmaceutical Company always adheres to the concept that people-oriented and safety is the cornerstone of enterprise development, and has a set of perfect safety management rules and regulations. The first responsibility system every year is the safety responsibility system signed with subordinate departments and the safety responsibility letter signed with all employees. At the same time, make full use of existing resources, improve various safety management measures, increase investment in safety production facilities and equipment, and passed the certification of three-level safety standardization enterprises in
. In daily production and operation, Chinese medicine companies pay attention to strengthening the education of the concept of safe production, strengthen the inspection of safe production and operation, and impose severe penalties on violations of safe production management regulations.
7# In February, cigarette butts were found during the safety inspection in the drug storage area of the storage department where fireworks are strictly prohibited. A meeting of members of the management team and a meeting of members of the safety committee was immediately held to seriously criticize and educate the relevant personnel. The directors and deputy directors of the storage department, the storehouse keeper and the members of the company's team were also given serious criticism and education, full-time safety officers and other relevant management personnel carry out different amounts of assessment and punishment from 1000 to 300 yuan, and also carry out comprehensive safety production inspection and rectification within the scope of the company, so that all employees can get an education on safety production management from this incident and strengthen the awareness of safety production. In normal work, the pharmaceutical company also requires the heads of all departments to strengthen inspections on the safe use of water and electricity, the closing of office doors and windows after work, and the power failure of electrical appliances. If violations are found, serious assessment will be carried out, and everyone will work together to eliminate potential safety hazards. The company conducts fire fighting and evacuation drills twice a year, and invites experts and teachers to conduct fire safety knowledge training from time to time to strengthen employees' safety awareness and enhance employees' safety knowledge and skills.
Safety management is composed of many factors such as ideology, safety standards, management concepts, system construction, etc. It should be based on the principle of people-oriented, not afraid of resistance, adhere to principles, dare to manage, and effectively manage the details of safety production. Combine with reward and punishment management, give full play to the rigidity of system implementation, make the parties feel pain and leave a mark in their hearts, at the same time, it also serves as a warning and spur to other employees, recognizes the necessity and importance of safe production work, and roots the awareness of safe production in their minds, so as to truly improve the safety awareness and safety literacy of all employees, and eliminate hidden dangers in safe production. Curb the occurrence of safety production accidents. Only by strict safety and civilized management can employees work and live in a safe and comfortable environment.
Therefore, safe and civilized work needs to be managed, and safe and civilized work is also managed. (Pharmaceutical Company
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31